Finance

Beta
Lists
OSCR:NYSE
Oscar Health Inc
$28.54
+0.49%
(+0.14) 1D
$28.70
+0.56% (+0.16)
After hours
Closed: Jun 22, 4:00:07 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OSCR...
Open
$28.32
High
$29.53
Low
$28.30
Mkt. cap
8.60B
Avg. vol.
8.22M
Volume
5.19M
52-wk high
$29.81
52-wk low
$10.69
EPS
-$0.61
Beta
2.37
Shares outstanding
265.90M
No. of employees
2K
Open
$28.32
High
$29.53
Low
$28.30
Mkt. cap
8.60B
Avg. vol.
8.22M
Volume
5.19M
52-wk high
$29.81
52-wk low
$10.69
EPS
-$0.61
Beta
2.37
Shares outstanding
265.90M
No. of employees
2K
News stories
From sources across the web
Profile
Oscar Management Corporation, doing business as Oscar Health is an American for-profit health insurance company, founded in 2012 by Joshua Kushner, Kevin Nazemi and Mario Schlosser, and is headquartered in New York City. The company focuses on the health insurance industry through telemedicine, healthcare focused technological interfaces, and transparent claims pricing systems which would make it easier for patients to navigate. Wikipedia
About Oscar Health Inc
CEOMark Bertolini
Employees2.3K
FoundedNov 1, 2012
HeadquartersNew York, New York, United States
SectorInsurance
Websitehioscar.com
Analyst Ratings
Based on 8 analysts giving stock ratings to OSCR in the past 3 months
Hold
Buy
1
Hold
6
Sell
1
12 month forecast
Based on 8 Wall Street analysts offering 12 month price targets for OSCR in the last 3 months.
Highest
Current $28.54
$35.00 (+22.63%)
Average
$20.71 (-27.44%)
Lowest
$13.00 (-54.45%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Andrew Mok CFA
Barclays
Buy
Upgraded
$35.00
+22.6%
06/10/2026
Stephen Baxter
Wells Fargo
Hold
Upgraded
$20.00
-29.9%
06/04/2026
Scott Fidel
Goldman Sachs
Hold
Reiterated
$22.00
-22.9%
05/11/2026
Michael Ha
Robert W. Baird
Hold
Maintained
$19.00
-33.4%
05/07/2026
Michael Craig Jones
Bank of America Securities
Sell
Maintained
$13.00
-54.4%
05/07/2026
Jonathan Yong
UBS
Hold
Maintained
$20.00
-29.9%
05/07/2026
Justin Lake
Wolfe Research
Hold
Initiated
-
-
05/05/2026
David Windley
Jefferies
Hold
Upgraded
$16.00
-43.9%
04/20/2026
John Ransom
Raymond James
Buy
Upgraded
$18.00
-36.9%
02/12/2026
Raj Kumar CFA
Stephens
Hold
Maintained
$17.00
-40.4%
02/11/2026
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$2.07 / $1.10
+88.18%beat
Revenue / Est. (USD)
4.65B / 4.92B
-5.49%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.86B
2.99B
2.81B
4.65B
Cost of goods sold
2.55B
2.59B
2.62B
3.23B
Cost of revenue
2.55B
2.59B
2.62B
3.23B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
534.48M
521.59M
511.03M
706.23M
Operating expense
541.46M
528.90M
518.91M
713.25M
Total operating expenses
3.09B
3.12B
3.14B
3.94B
Operating income
-230.48M
-129.25M
-333.75M
704.08M
Other non operating income
2.79M
-3.18M
-20.03M
71.00K
EBT including unusual items
-233.54M
-139.29M
-352.68M
698.77M
EBT excluding unusual items
-233.54M
-139.29M
-352.68M
698.77M
Income tax expense
-5.04M
-1.81M
-247.00K
19.75M
Effective tax rate
2.16%
1.30%
0.07%
2.83%
Other operating expenses
-
-
-
-
Net income
-228.36M
-137.45M
-352.61M
679.00M
Net profit margin
-7.97%
-4.60%
-12.57%
14.61%
Earnings per share
-0.89
-0.53
-1.24
2.07
Interest and investment income
-
-
1.10M
-
Interest expense
-5.85M
-6.86M
-
-5.38M
Net interest expenses
-5.85M
-6.86M
1.10M
-5.38M
Depreciation and amortization charges
6.97M
7.31M
7.88M
7.02M
EBITDA
-223.51M
-121.94M
-325.87M
711.10M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer